Newsroom
Sorted by: Latest
-
nPhase Secures $30 Million in Series D Funding to Drive Global Expansion of AI-Native Clinical Data Platform for Life Sciences
ATLANTIC BEACH, Fla.--(BUSINESS WIRE)--nPhase, Inc., today announced the closing of a $30 million Series D funding round led by Viking Global Investors to accelerate the company’s AI-native clinical data platform for pharmaceutical sponsors seeking to unlock the full potential of their data and power AI at scale. Viking Global Investors is an investment firm managing more than $54 billion in capital across public and private investments. The financing represents nPhase’s first equity capital ra...
-
AvaSure Names Patric Edmondson Chief Technology Officer
BELMONT, Mich.--(BUSINESS WIRE)--AvaSure names Patric Edmondson as Chief Technology Officer....
-
Rare Earths Americas Reports 48% Improvement in Rare Earth Leach Recovery at Alpha as Initial Assessment Nears Completion
BAHIA, Brazil--(BUSINESS WIRE)--Rare Earths Americas, Inc. (“REA” or the “Company”) announced results from an initial series of laboratory leach tests performed by SGS on material from its Alpha Project. The tests address a key remaining input to Alpha’s Initial Assessment (“IA”), which is over 80% complete and remains targeted for release in the first quarter of 2027. The IA is expected to evaluate a preliminary mine plan, production schedule, processing approach, capital and operating costs,...
-
Marvell and Lumentum to Combine, Creating a Category Leader in AI Connectivity
SANTA CLARA, Calif. & SAN JOSE, Calif.--(BUSINESS WIRE)--Marvell Technology, Inc. (NASDAQ: MRVL) and Lumentum (NASDAQ: LITE) today announced that they have entered into a definitive agreement for Marvell to acquire Lumentum in an all-stock transaction. Under the terms of the agreement, Lumentum stockholders will receive a fixed exchange ratio of 4.500 shares of Marvell common stock for each share of Lumentum common stock they own. The transaction has an implied enterprise value of $115 billion...
-
Content Catalyst Launches Gateway Catalyst, Governed AI Access for Analyst Firms’ Research
CAMBRIDGE, England--(BUSINESS WIRE)--Content Catalyst launches Gateway Catalyst, giving analyst firms governed access to their research in AI assistants with no build required....
-
Stonepeak Completes Acquisition of Majority Controlling Interest in Castrol From bp
LONDON & NEW YORK--(BUSINESS WIRE)--Stonepeak, a leading alternative investment firm specialising in infrastructure, today announced it has completed the acquisition of a 65% stake in Castrol, a global leader in lubricants, from BP p.l.c. (“bp”) (NYSE: BP) (LON: BP). bp will retain a 35% minority interest in Castrol. With Stonepeak’s backing and continued support from bp, Castrol will build on its position as one of the world’s largest providers of mission-critical lubricants and thermal manage...
-
Eptura Names First Chief AI Officer
ATLANTA--(BUSINESS WIRE)--Eptura today announced the appointment of Nuala Larkin as its first Chief AI Officer (CAIO)....
-
Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress...
-
AN2 Therapeutics Receives U.S. FDA IND Clearance to Proceed with Planned Phase 2 Global Study of Oral Epetraborole in Polycythemia Vera
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for epetraborole in polycythemia vera (PV). The Company has now received regulatory clearance in all planned jurisdictions (A...
-
All U Need Pest Control Partners with Golden Gate Capital on Recapitalization
SAN FRANCISCO & FORT MYERS, Fla.--(BUSINESS WIRE)--Golden Gate Capital, a San Francisco-based private equity firm, today announced the recapitalization of All U Need Pest Control (the “Company”), one of the fastest-growing pest control companies in the U.S. Steve Groeper, Founder and Executive Chairman, and Kyle Selbach, CEO, will continue to lead the Company and remain shareholders along with the broader senior leadership team. Terms of the transaction were not disclosed. All U Need Pest Contr...